The Posterior Pituitary Contains a Potent Prolactin-Releasing Factor:In VivoStudies*
- 1 August 1989
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 125 (2), 736-741
- https://doi.org/10.1210/endo-125-2-736
Abstract
The posterior pituitary contains a PRL-releasing factor (PRF), a small (<500 mol wt) peptide which is distinct from known PRL secretagogues. The objective of this study were to determine if posterior pituitary extracts specifically stimulate PRL release in vivo and to assess the relative contributions of oxytocin (OT), arginine vasopressin (AVP), and .beta.-endorphin (.beta.END) to the PRF activity of the extract. Rat posterior pituitaries or cerebellar tissue were extracted with 1.0 N acetic acid, boiled, and ultrafiltered through 5000 mol wt cut-off membranes. The eluates were treated with performic acid (which oxidizes bonds and methionine residues), lyophilized, and reconstituted in saline. Jugular blood was collected from conscious ovariectomized rats before and after intracarotid injection of test substances and was analyzed for PRL, LH, and GH by RIA. Injection of 0.3, 1.0, and 3.0, posterior pituitary equivalents increased plasma PRL levels by 2- 8-, and 22-fold respectively. PRL levels peaked within 5 min after the injection and returned to basal levels by 30 min. Plasma LH levels decreased slightly, and GH was unchanged. Cerebellar extracts did not affect plasma hormone levels. Injection of OT induced a 4-fold rise in plasma PRL levels. Oxidation of OT as well as AVP with performic acid abolished any PRL-releasing activity. Injection of .beta.END increased plasma PRL levels by 7-fold. Treatment of .beta.END with perfomic acid caused a 60% loss in its ability to release PRL. Pretreatment of rats with naloxone abolished the PRL-releasing effect of .beta.END, but did not alter the PRF activity of posterior pituitary extracts. We conclude that posterior pituitary extracts stimulate PRL release in vico in the presence of an intact dopaminergic inhibition. This stimulation is rapid, dose dependent, and hormone specific. OT, AVP, and .beta.END do not contribute significantly to the PRF activity in the posterior pituitary extract.This publication has 14 references indexed in Scilit:
- Posterior Pituitary Lobectomy Abolishes the Suckling-Induced Rise in Prolactin (PRL): Evidence for a PRLReleasing Factor in the Posterior Pituitary*Endocrinology, 1987
- Evidence for a Physiological Role for Oxytocin in the Control of Prolactin Secretion*Endocrinology, 1986
- Bovine Neurophysin II Has Prolactin-Releasing Activity in the Estradiol-Primed Male RatNeuroendocrinology, 1985
- Hypothalamic and Pituitary Sites of Action of Oxytocin to Alter Prolactin Secretion in the Rat*Endocrinology, 1983
- Failure of β-Endorphin to Stimulate Prolactin Release in the Pituitary Stalk-Sectioned Monkey*Endocrinology, 1980
- Morphine differentially alters synthesis and turnover of dopamine in central neuronal systemsJournal of Neural Transmission, 1980
- Location and characterization of opiate receptors regulating pituitary secretionLife Sciences, 1980
- Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neuronsLife Sciences, 1979
- STIMULATION IN VIVO OF THE SECRETION OF PROLACTIN AND GROWTH HORMONE BY β-ENDORPHINEndocrinology, 1977
- In vitro inhibition of pituitary prolactin synthesis and release by hypothalamic extractAmerican Journal of Physiology-Legacy Content, 1963